Neuronal hyperactivity - A key defect in Alzheimer's disease?

被引:166
|
作者
Busche, Marc Aurel [1 ,2 ,3 ,4 ]
Konnerth, Arthur [1 ,3 ,4 ]
机构
[1] Tech Univ Munich, Inst Neurosci, D-80290 Munich, Germany
[2] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany
[3] Tech Univ Munich, Munich Cluster Syst Neurol SyNergy, D-80290 Munich, Germany
[4] Tech Univ Munich, Ctr Integrated Prot Sci CIPSM, D-80290 Munich, Germany
关键词
Alzheimer's disease; amyloid-ss; biomedicine; brain imaging; mouse models; neuronal dysfunction; neuronal hyperactivity; AMYLOID-BETA-PROTEIN; TRANSGENIC MOUSE MODELS; HIPPOCAMPAL ACTIVATION; PRECURSOR-PROTEIN; MEMORY DEFICITS; COGNITIVE IMPAIRMENTS; RELEASE PROBABILITY; HYPOTHETICAL MODEL; APOLIPOPROTEIN-E; UNIT-ACTIVITY;
D O I
10.1002/bies.201500004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Traditionally, the impairment of cognitive functions in Alzheimers disease (AD) is thought to result from a reduction in neuronal and synaptic activities, and ultimately cell death. Here, we review recent in vivo evidence from mouse models and human patients indicating that, particularly in early stages of AD, neuronal circuits are hyperactive instead of hypoactive. Functional analyses at many levels, from single neurons to neuronal populations to large-scale networks, with a variety of electrophysiological and imaging techniques have revealed two forms of AD-related hyperactivity and provided first insights into the synaptic mechanisms. The unexpected finding that hyperactivity is an early neuronal dysfunction represents a major conceptual shift in our understanding of AD that may have important implications for the development of therapeutic approaches.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 50 条
  • [21] RyR2-dependent modulation of neuronal hyperactivity: A potential therapeutic target for treating Alzheimer's disease
    Yao, Jinjing
    Chen, S. R. Wayne
    JOURNAL OF PHYSIOLOGY-LONDON, 2024, 602 (08): : 1509 - 1518
  • [22] Intracellular Ca2+ stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer's disease
    Lerdkrai, Chommanad
    Asavapanumas, Nithi
    Brawek, Bianca
    Kovalchuk, Yury
    Mojtahedi, Nima
    del Moral, Maria Olmedillas
    Garaschuk, Olga
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (06) : E1279 - E1288
  • [23] Dysregulation of Neuronal Iron in Alzheimer's Disease
    Uddin, Md. Sahab
    Ashraf, Ghulam Md
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (11) : 2247 - 2250
  • [24] Neuronal histamine deficit in Alzheimer's disease
    Panula, P
    Rinne, J
    Kuokkanen, K
    Eriksson, K
    Sallmen, T
    Kalimo, H
    Relja, M
    NEUROSCIENCE, 1998, 82 (04) : 993 - 997
  • [25] Neuronal protection by sirtuins in Alzheimer's disease
    Anekonda, TS
    Reddy, PH
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 (02) : 305 - 313
  • [26] Mechanism for neuronal apoptosis in Alzheimer's disease
    Subhani, Farhan U.
    BRAIN PATHOLOGY, 2006, 16 : S122 - S122
  • [27] Alzheimer’s Disease and Neuronal Network Activity
    Marc Gleichmann
    Mark P. Mattson
    NeuroMolecular Medicine, 2010, 12 : 44 - 47
  • [28] Cholesterol, neuronal activity and Alzheimer's disease
    Pierrot, Nathalie
    Octave, Jean-Noel
    M S-MEDECINE SCIENCES, 2014, 30 (03): : 244 - 246
  • [29] Selective neuronal vulnerability in Alzheimer's disease
    Wang, Zuo-Teng
    Zhang, Can
    Wang, Yan-Jiang
    Dong, Qiang
    Tan, Lan
    Yu, Jin-Tai
    AGEING RESEARCH REVIEWS, 2020, 62
  • [30] Mechanisms of neuronal death in Alzheimer's disease
    Cotman, CW
    Su, JH
    BRAIN PATHOLOGY, 1996, 6 (04) : 493 - 506